{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T15:03:52Z","timestamp":1771859032641,"version":"3.50.1"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,9,18]]},"DOI":"10.7759\/cureus.18088","type":"journal-article","created":{"date-parts":[[2021,9,19]],"date-time":"2021-09-19T06:45:30Z","timestamp":1632033930000},"source":"Crossref","is-referenced-by-count":4,"title":["Role of Hydrogen Sulfide in the Treatment of Fibrosis"],"prefix":"10.7759","author":[{"given":"Swathy S","family":"Chirindoth","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ivan","family":"Cancarevic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4939-7113-8_1","article-title":"Human fibrotic diseases: current challenges in fibrosis research","author":"Rosenbloom J","year":"2017","unstructured":"Rosenbloom J, Macarak E, Piera-Velazquez S, Jimenez SA. Human fibrotic diseases: current challenges in fibrosis research. Fibrosis. Methods in Molecular Biology. Ritti\u00e9 L (ed): Humana Press, New York, NY; 2017. 1627:1-23. 10.1007\/978-1-4939-7113-8_1"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1038\/nm.2807","article-title":"Mechanisms of fibrosis: therapeutic translation for fibrotic disease","volume":"18","author":"Wynn TA","year":"2012","unstructured":"Wynn TA, Ramalingam TR. Mechanisms of fibrosis: therapeutic translation for fibrotic disease. Nat Med. 2012, 18:1028-40. 10.1038\/nm.2807","journal-title":"Nat Med"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20190103","article-title":"Transforming growth factor-\u03b2 in tissue fibrosis","volume":"217","author":"Frangogiannis N","year":"2020","unstructured":"Frangogiannis N. Transforming growth factor-\u03b2 in tissue fibrosis. J Exp Med. 2020, 217:e20190103. 10.1084\/jem.20190103","journal-title":"J Exp Med"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2014.00123","article-title":"Fibroblasts in fibrosis: novel roles and mediators","volume":"5","author":"Kendall RT","year":"2014","unstructured":"Kendall RT, Feghali-Bostwick CA. Fibroblasts in fibrosis: novel roles and mediators. Front Pharmacol. 2014, 5:123. 10.3389\/fphar.2014.00123","journal-title":"Front Pharmacol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1186\/s12931-019-1161-4","article-title":"Antifibrotic therapy for idiopathic pulmonary fibrosis: time to treat","volume":"20","author":"Maher TM","year":"2019","unstructured":"Maher TM, Strek ME. Antifibrotic therapy for idiopathic pulmonary fibrosis: time to treat. Respir Res. 2019, 20:205. 10.1186\/s12931-019-1161-4","journal-title":"Respir Res"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmb.2016.12.015","article-title":"Functional and molecular insights of hydrogen sulfide signaling and protein sulfhydration","volume":"429","author":"Sen N","year":"2017","unstructured":"Sen N. Functional and molecular insights of hydrogen sulfide signaling and protein sulfhydration. J Mol Biol. 2017, 429:543-61. 10.1016\/j.jmb.2016.12.015","journal-title":"J Mol Biol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/593407","article-title":"Hydrogen sulfide as a potential therapeutic target in fibrosis","volume":"2015","author":"Zhang S","year":"2015","unstructured":"Zhang S, Pan C, Zhou F, Yuan Z, Wang H, Cui W, Zhang G. Hydrogen sulfide as a potential therapeutic target in fibrosis. Oxid Med Cell Longev. 2015, 2015:593407. 10.1155\/2015\/593407","journal-title":"Oxid Med Cell Longev"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/357824","article-title":"Hydrogen sulfide signaling in oxidative stress and aging development","volume":"2015","author":"Yang G","year":"2015","unstructured":"Yang G, An SS, Ji Y, Zhang W, Pei Y. Hydrogen sulfide signaling in oxidative stress and aging development. Oxid Med Cell Longev. 2015, 2015:357824. 10.1155\/2015\/357824","journal-title":"Oxid Med Cell Longev"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1038\/ki.2009.86","article-title":"Ureteral obstruction as a model of renal interstitial fibrosis and obstructive nephropathy","volume":"75","author":"Chevalier RL","year":"2009","unstructured":"Chevalier RL, Forbes MS, Thornhill BA. Ureteral obstruction as a model of renal interstitial fibrosis and obstructive nephropathy. Kidney Int. 2009, 75:1145-52. 10.1038\/ki.2009.86","journal-title":"Kidney Int"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2006030267","article-title":"Why kidneys fail: report from an American Society of Nephrology Advances in Research Conference","volume":"17","author":"Schnaper HW","year":"2006","unstructured":"Schnaper HW, Kopp JB. Why kidneys fail: report from an American Society of Nephrology Advances in Research Conference. J Am Soc Nephrol. 2006, 17:1777-81. 10.1681\/ASN.2006030267","journal-title":"J Am Soc Nephrol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharep.2017.10.007","article-title":"The smell of renal protection against chronic kidney disease: hydrogen sulfide offers a potential stinky remedy","volume":"70","author":"Dugbartey GJ","year":"2018","unstructured":"Dugbartey GJ. The smell of renal protection against chronic kidney disease: hydrogen sulfide offers a potential stinky remedy. Pharmacol Rep. 2018, 70:196-205. 10.1016\/j.pharep.2017.10.007","journal-title":"Pharmacol Rep"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/458720","article-title":"Hydrogen sulfide: a therapeutic candidate for fibrotic disease?","volume":"2015","author":"Song K","year":"2015","unstructured":"Song K, Li Q, Yin XY, Lu Y, Liu CF, Hu LF. Hydrogen sulfide: a therapeutic candidate for fibrotic disease?. Oxid Med Cell Longev. 2015, 2015:458720. 10.1155\/2015\/458720","journal-title":"Oxid Med Cell Longev"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.freeradbiomed.2017.08.017","article-title":"Hydrogen sulfide-producing cystathionine \u03b3-lyase is critical in the progression of kidney fibrosis","volume":"112","author":"Han SJ","year":"2017","unstructured":"Han SJ, Noh MR, Jung JM, Ishii I, Yoo J, Kim JI, Park KM. Hydrogen sulfide-producing cystathionine \u03b3-lyase is critical in the progression of kidney fibrosis. Free Radic Biol Med. 2017, 112:423-32. 10.1016\/j.freeradbiomed.2017.08.017","journal-title":"Free Radic Biol Med"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1097\/CM9.0000000000000537","article-title":"Involvement of hydrogen sulfide in the progression of renal fibrosis","volume":"132","author":"Wang Y","year":"2019","unstructured":"Wang Y, Xing QQ, Tu JK, et al.. Involvement of hydrogen sulfide in the progression of renal fibrosis. Chin Med J (Engl). 2019, 132:2872-80. 10.1097\/CM9.0000000000000537","journal-title":"Chin Med J (Engl)"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.2174\/1871530318666180426100532","article-title":"Hydrogen sulfide in diabetic complications: focus on molecular mechanisms","volume":"18","author":"Qian LL","year":"2018","unstructured":"Qian LL, Liu XY, Chai Q, Wang RX. Hydrogen sulfide in diabetic complications: focus on molecular mechanisms. Endocr Metab Immune Disord Drug Targets. 2018, 18:470-6. 10.2174\/1871530318666180426100532","journal-title":"Endocr Metab Immune Disord Drug Targets"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.3390\/molecules24152857","article-title":"Hydrogen sulfide: recent progression and perspectives for the treatment of diabetic nephropathy","volume":"24","author":"Sun HJ","year":"2019","unstructured":"Sun HJ, Wu ZY, Cao L, et al.. Hydrogen sulfide: recent progression and perspectives for the treatment of diabetic nephropathy. Molecules. 2019, 24:2857. 10.3390\/molecules24152857","journal-title":"Molecules"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.niox.2018.03.002","article-title":"Daily therapy with a slow-releasing H2S donor GYY4137 enables early functional recovery and ameliorates renal injury associated with urinary obstruction","volume":"76","author":"Lin S","year":"2018","unstructured":"Lin S, Lian D, Liu W, et al.. Daily therapy with a slow-releasing H2S donor GYY4137 enables early functional recovery and ameliorates renal injury associated with urinary obstruction. Nitric Oxide. 2018, 76:16-28. 10.1016\/j.niox.2018.03.002","journal-title":"Nitric Oxide"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1002\/nau.22450","article-title":"Exogenous hydrogen sulfide prevents kidney damage following unilateral ureteral obstruction","volume":"33","author":"Jiang D","year":"2014","unstructured":"Jiang D, Zhang Y, Yang M, Wang S, Jiang Z, Li Z. Exogenous hydrogen sulfide prevents kidney damage following unilateral ureteral obstruction. Neurourol Urodyn. 2014, 33:538-43. 10.1002\/nau.22450","journal-title":"Neurourol Urodyn"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1590\/S1677-5538.IBJU.2014.0090","article-title":"Protective effect of hydrogen sulfide on renal injury in the experimental unilateral ureteral obstruction","volume":"41","author":"Dursun M","year":"2015","unstructured":"Dursun M, Otunctemur A, Ozbek E, et al.. Protective effect of hydrogen sulfide on renal injury in the experimental unilateral ureteral obstruction. Int Braz J Urol. 2015, 41:1185-93. 10.1590\/S1677-5538.IBJU.2014.0090","journal-title":"Int Braz J Urol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1007\/s11357-018-0018-y","article-title":"Hydrogen sulfide ameliorates aging-associated changes in the kidney","volume":"40","author":"Lee HJ","year":"2018","unstructured":"Lee HJ, Feliers D, Barnes JL, et al.. Hydrogen sulfide ameliorates aging-associated changes in the kidney. Geroscience. 2018, 40:163-76. 10.1007\/s11357-018-0018-y","journal-title":"Geroscience"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2013.06.015","article-title":"Involvement of hydrogen sulfide and homocysteine transsulfuration pathway in the progression of kidney fibrosis after ureteral obstruction","volume":"1832","author":"Jung KJ","year":"2013","unstructured":"Jung KJ, Jang HS, Kim JI, Han SJ, Park JW, Park KM. Involvement of hydrogen sulfide and homocysteine transsulfuration pathway in the progression of kidney fibrosis after ureteral obstruction. Biochim Biophys Acta. 2013, 1832:1989-97. 10.1016\/j.bbadis.2013.06.015","journal-title":"Biochim Biophys Acta"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1016\/j.niox.2014.02.006","article-title":"Hydrogen sulfide and the liver","volume":"41","author":"Mani S","year":"2014","unstructured":"Mani S, Cao W, Wu L, Wang R. Hydrogen sulfide and the liver. Nitric Oxide. 2014, 41:62-71. 10.1016\/j.niox.2014.02.006","journal-title":"Nitric Oxide"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.3892\/mmr.2012.1153","article-title":"Protective effects of hydrogen sulfide on oxidative stress and fibrosis in hepatic stellate cells","volume":"7","author":"Fan HN","year":"2013","unstructured":"Fan HN, Wang HJ, Yang-Dan CR, Ren L, Wang C, Li YF, Deng Y. Protective effects of hydrogen sulfide on oxidative stress and fibrosis in hepatic stellate cells. Mol Med Rep. 2013, 7:247-53. 10.3892\/mmr.2012.1153","journal-title":"Mol Med Rep"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1155\/2017\/1406726","article-title":"Diallyl trisulfide suppresses oxidative stress-induced activation of hepatic stellate cells through production of hydrogen sulfide","volume":"2017","author":"Zhang F","year":"2017","unstructured":"Zhang F, Jin H, Wu L, Shao J, Zhu X, Chen A, Zheng S. Diallyl trisulfide suppresses oxidative stress-induced activation of hepatic stellate cells through production of hydrogen sulfide. Oxid Med Cell Longev. 2017, 2017:1406726. 10.1155\/2017\/1406726","journal-title":"Oxid Med Cell Longev"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1093\/cvr\/cvq329","article-title":"Molecular determinants of cardiac fibroblast electrical function and therapeutic implications for atrial fibrillation","volume":"89","author":"Yue L","year":"2011","unstructured":"Yue L, Xie J, Nattel S. Molecular determinants of cardiac fibroblast electrical function and therapeutic implications for atrial fibrillation. Cardiovasc Res. 2011, 89:744-53. 10.1093\/cvr\/cvq329","journal-title":"Cardiovasc Res"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1161\/01.res.0000046452.67724.b8","article-title":"Gene expression in fibroblasts and fibrosis: involvement in cardiac hypertrophy","volume":"91","author":"Manabe I","year":"2002","unstructured":"Manabe I, Shindo T, Nagai R. Gene expression in fibroblasts and fibrosis: involvement in cardiac hypertrophy. Circ Res. 2002, 91:1103-13. 10.1161\/01.res.0000046452.67724.b8","journal-title":"Circ Res"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1161\/01.res.72.6.1245","article-title":"Angiotensin II is mitogenic in neonatal rat cardiac fibroblasts","volume":"72","author":"Schorb W","year":"1993","unstructured":"Schorb W, Booz GW, Dostal DE, Conrad KM, Chang KC, Baker KM. Angiotensin II is mitogenic in neonatal rat cardiac fibroblasts. Circ Res. 1993, 72:1245-54. 10.1161\/01.res.72.6.1245","journal-title":"Circ Res"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1006\/jmcc.2000.1129","article-title":"Induction of cardiac fibrosis by aldosterone","volume":"32","author":"Lijnen P","year":"2000","unstructured":"Lijnen P, Petrov V. Induction of cardiac fibrosis by aldosterone. J Mol Cell Cardiol. 2000, 32:865-79. 10.1006\/jmcc.2000.1129","journal-title":"J Mol Cell Cardiol"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2015.11.025","article-title":"Hydrogen sulfide suppresses endoplasmic reticulum stress-induced endothelial-to-mesenchymal transition through Src pathway","volume":"144","author":"Ying R","year":"2016","unstructured":"Ying R, Wang XQ, Yang Y, et al.. Hydrogen sulfide suppresses endoplasmic reticulum stress-induced endothelial-to-mesenchymal transition through Src pathway. Life Sci. 2016, 144:208-17. 10.1016\/j.lfs.2015.11.025","journal-title":"Life Sci"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1111\/bph.12825","article-title":"Exogenous administration of thiosulfate, a donor of hydrogen sulfide, attenuates angiotensin II-induced hypertensive heart disease in rats","volume":"172","author":"Snijder PM","year":"2015","unstructured":"Snijder PM, Frenay AR, de Boer RA, Pasch A, Hillebrands JL, Leuvenink HG, van Goor H. Exogenous administration of thiosulfate, a donor of hydrogen sulfide, attenuates angiotensin II-induced hypertensive heart disease in rats. Br J Pharmacol. 2015, 172:1494-504. 10.1111\/bph.12825","journal-title":"Br J Pharmacol"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/925167","article-title":"The cardioprotective effects of hydrogen sulfide in heart diseases: from molecular mechanisms to therapeutic potential","volume":"2015","author":"Shen Y","year":"2015","unstructured":"Shen Y, Shen Z, Luo S, Guo W, Zhu YZ. The cardioprotective effects of hydrogen sulfide in heart diseases: from molecular mechanisms to therapeutic potential. Oxid Med Cell Longev. 2015, 2015:925167. 10.1155\/2015\/925167","journal-title":"Oxid Med Cell Longev"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1111\/jcmm.12114","article-title":"Hydrogen sulphide suppresses human atrial fibroblast proliferation and transformation to myofibroblasts","volume":"17","author":"Sheng J","year":"2013","unstructured":"Sheng J, Shim W, Wei H, et al.. Hydrogen sulphide suppresses human atrial fibroblast proliferation and transformation to myofibroblasts. J Cell Mol Med. 2013, 17:1345-54. 10.1111\/jcmm.12114","journal-title":"J Cell Mol Med"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1016\/j.yjmcc.2015.07.028","article-title":"GYY4137 attenuates remodeling, preserves cardiac function and modulates the natriuretic peptide response to ischemia","volume":"87","author":"Lilyanna S","year":"2015","unstructured":"Lilyanna S, Peh MT, Liew OW, Wang P, Moore PK, Richards AM, Martinez EC. GYY4137 attenuates remodeling, preserves cardiac function and modulates the natriuretic peptide response to ischemia. J Mol Cell Cardiol. 2015, 87:27-37. 10.1016\/j.yjmcc.2015.07.028","journal-title":"J Mol Cell Cardiol"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/691070","article-title":"Hydrogen sulfide donor GYY4137 protects against myocardial fibrosis","volume":"2015","author":"Meng G","year":"2015","unstructured":"Meng G, Zhu J, Xiao Y, et al.. Hydrogen sulfide donor GYY4137 protects against myocardial fibrosis. Oxid Med Cell Longev. 2015, 2015:691070. 10.1155\/2015\/691070","journal-title":"Oxid Med Cell Longev"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0019766","article-title":"Hydrogen sulfide attenuated tumor necrosis factor-\u03b1-induced inflammatory signaling and dysfunction in vascular endothelial cells","volume":"6","author":"Pan LL","year":"2011","unstructured":"Pan LL, Liu XH, Gong QH, Wu D, Zhu YZ. Hydrogen sulfide attenuated tumor necrosis factor-\u03b1-induced inflammatory signaling and dysfunction in vascular endothelial cells. PLoS One. 2011, 6:e19766. 10.1371\/journal.pone.0019766","journal-title":"PLoS One"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1152\/ajpheart.00682.2009","article-title":"H2S ameliorates oxidative and proteolytic stresses and protects the heart against adverse remodeling in chronic heart failure","volume":"298","author":"Mishra PK","year":"2010","unstructured":"Mishra PK, Tyagi N, Sen U, Givvimani S, Tyagi SC. H2S ameliorates oxidative and proteolytic stresses and protects the heart against adverse remodeling in chronic heart failure. Am J Physiol Heart Circ Physiol. 2010, 298:H451-6. 10.1152\/ajpheart.00682.2009","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.3892\/mmr.2012.748","article-title":"Hydrogen sulfide attenuates cardiac hypertrophy and fibrosis induced by abdominal aortic coarctation in rats","volume":"5","author":"Huang J","year":"2012","unstructured":"Huang J, Wang D, Zheng J, Huang X, Jin H. Hydrogen sulfide attenuates cardiac hypertrophy and fibrosis induced by abdominal aortic coarctation in rats. Mol Med Rep. 2012, 5:923-8. 10.3892\/mmr.2012.748","journal-title":"Mol Med Rep"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1159\/000156486","article-title":"Cardioprotective role of sodium thiosulfate on chronic heart failure by modulating endogenous H2S generation","volume":"82","author":"Sen U","year":"2008","unstructured":"Sen U, Vacek TP, Hughes WM, et al.. Cardioprotective role of sodium thiosulfate on chronic heart failure by modulating endogenous H2S generation. Pharmacology. 2008, 82:201-13. 10.1159\/000156486","journal-title":"Pharmacology"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1042\/BSR20100003","article-title":"Hydrogen sulfide attenuates cardiac dysfunction in a rat model of heart failure: a mechanism through cardiac mitochondrial protection","volume":"31","author":"Wang X","year":"2011","unstructured":"Wang X, Wang Q, Guo W, Zhu YZ. Hydrogen sulfide attenuates cardiac dysfunction in a rat model of heart failure: a mechanism through cardiac mitochondrial protection. Biosci Rep. 2011, 31:87-98. 10.1042\/BSR20100003","journal-title":"Biosci Rep"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.7150\/ijbs.3632","article-title":"Hydrogen sulfide mitigates cardiac remodeling during myocardial infarction via improvement of angiogenesis","volume":"8","author":"Qipshidze N","year":"2012","unstructured":"Qipshidze N, Metreveli N, Mishra PK, Lominadze D, Tyagi SC. Hydrogen sulfide mitigates cardiac remodeling during myocardial infarction via improvement of angiogenesis. Int J Biol Sci. 2012, 8:430-41. 10.7150\/ijbs.3632","journal-title":"Int J Biol Sci"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.2147\/IJN.S216667","article-title":"A novel liposomal S-propargyl-cysteine: a sustained release of hydrogen sulfide reducing myocardial fibrosis via TGF-\u03b21\/Smad pathway","volume":"14","author":"Tran BH","year":"2019","unstructured":"Tran BH, Yu Y, Chang L, et al.. A novel liposomal S-propargyl-cysteine: a sustained release of hydrogen sulfide reducing myocardial fibrosis via TGF-\u03b21\/Smad pathway. Int J Nanomedicine. 2019, 14:10061-77. 10.2147\/IJN.S216667","journal-title":"Int J Nanomedicine"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1016\/j.resp.2012.03.009","article-title":"The message in the air: hydrogen sulfide metabolism in chronic respiratory diseases","volume":"184","author":"Chen Y","year":"2012","unstructured":"Chen Y, Wang R. The message in the air: hydrogen sulfide metabolism in chronic respiratory diseases. Respir Physiol Neurobiol. 2012, 184:130-8. 10.1016\/j.resp.2012.03.009","journal-title":"Respir Physiol Neurobiol"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1165\/rcmb.2017-0114TR","article-title":"Hydrogen sulfide: a novel player in airway development, pathophysiology of respiratory diseases, and antiviral defenses","volume":"57","author":"Bazhanov N","year":"2017","unstructured":"Bazhanov N, Ansar M, Ivanciuc T, Garofalo RP, Casola A. Hydrogen sulfide: a novel player in airway development, pathophysiology of respiratory diseases, and antiviral defenses. Am J Respir Cell Mol Biol. 2017, 57:403-10. 10.1165\/rcmb.2017-0114TR","journal-title":"Am J Respir Cell Mol Biol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/53431-role-of-hydrogen-sulfide-in-the-treatment-of-fibrosis","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:30:07Z","timestamp":1707507007000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/53431-role-of-hydrogen-sulfide-in-the-treatment-of-fibrosis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,18]]},"references-count":43,"URL":"https:\/\/doi.org\/10.7759\/cureus.18088","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9,18]]}}}